With the Medicare GLP-1 Bridge Program just 2 weeks old, a drug market expert shared their thoughts on what the initiative may mean for pharmacists and their patients.
Jay Bregman
Advertisement
Jay Bregman, founder and CEO of Andel
Articles by Jay Bregman
With GLP-1 questions creating confusion for Medicare patients, pharmacists are becoming the trusted frontline resource, and the stakes for getting it right have never been higher.
Jay Bregman, founder and CEO of Andel, discusses the current GLP-1 landscape and how a new Medicare initiative is designed to improve access to this increasingly popular medication class.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
Study Finds Dormant Viruses Reactivate During COVID-19
2
Confounding by Depression, Not SSRIs, Drives Most Pregnancy Risks
3
US Disease Tracker Launches to Monitor Vaccine-Preventable Illnesses
4
FDA Authorizes First Ketone, Blood Sugar Monitor for Diabetes
5